Viveka Frykmann-Kull

Title: **Inventor Viveka Frykmann-Kull: Innovating Cardiac Diagnosis**

Introduction

Viveka Frykmann-Kull, an accomplished inventor based in Vaxholm, Sweden, has made notable advancements in the medical technology field. She is recognized for her innovative approach to diagnosing atrial fibrillation, which significantly impacts the elderly population.

Latest Patents

Frykmann-Kull holds a patent for an innovative algorithm of NTproBNP and a handheld ECG device designed to detect arrhythmia in elderly patients. The invention outlines a method that includes determining the amount of a BNP-type peptide in a sample, comparing this amount to a reference, and assessing intermittent ECG recordings over a week. This method enhances the ability to diagnose atrial fibrillation in subjects without a known history of the condition, presenting a valuable tool for healthcare providers.

Career Highlights

Currently, Viveka is employed at Roche Diagnostics Operations, Inc., where she continues to contribute to groundbreaking medical solutions. Her work focuses on improving diagnostic techniques that benefit patient care and outcomes.

Collaborations

Throughout her career, Frykmann-Kull has collaborated with notable colleagues, including Mathias Emil Egermark and Edelgard Anna Kaiser. These partnerships reflect her commitment to teamwork and shared knowledge within the innovative environment at Roche.

Conclusion

Viveka Frykmann-Kull exemplifies the spirit of innovation within the realm of medical technology. Her dedication to enhancing cardiac care through her patented invention underscores the significance of her contributions to the field, and her efforts may pave the way for future advancements in diagnostic methodologies.